HuBit Genomix, Inc.
PrivateLast Round
Strategic
Mar 1, 2001
Company Overview
HuBit Genomix, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Strategic round in March 2001.
HuBit Genomix, Inc. is a biotechnology company that specializes in population genomics research, cohort studies, and drug discovery services for pharmaceutical and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HuBit Genomix, Inc. Comparables
Compare HuBit Genomix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A.D.A.M. Innovations Co. | 79% | |
| Sysmex Corporation | 76% | |
| Axcelead, Inc. | 68% |
For institutional investors. Book with your work email.
HuBit Genomix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 1, 2001 | ||||
| Seed | Apr 1, 2000 |
For institutional investors. Book with your work email.
HuBit Genomix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WHIZ Partners, Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2001
Completed a strategic funding round.
- Apr 1, 2000
Seed round led by WHIZ Partners, Inc.
For institutional investors. Book with your work email.
HuBit Genomix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HuBit Genomix, Inc.'s valuation, stock price, and market status.
Is HuBit Genomix, Inc. a public or private company?
HuBit Genomix, Inc. is a private company.
What is the current stock price of HuBit Genomix, Inc.?
HuBit Genomix, Inc. is a private company, so its shares have no public market price. Caplight tracks HuBit Genomix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HuBit Genomix, Inc. worth (valuation)?
Valuation information for HuBit Genomix, Inc. is not publicly available.
Can I buy HuBit Genomix, Inc. stock?
HuBit Genomix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HuBit Genomix, Inc.'s last funding round?
HuBit Genomix, Inc.'s most recent funding round was Strategic on March 1, 2001.
Who are the main investors in HuBit Genomix, Inc.?
Key investors in HuBit Genomix, Inc. include WHIZ Partners, Inc..
Will HuBit Genomix, Inc. IPO soon?
No public IPO plans have been announced for HuBit Genomix, Inc..
How can I track HuBit Genomix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in HuBit Genomix, Inc.'s shares on secondary markets.